NOVOTNÝ, Jan, Hana HRSTKOVÁ, Milan BAJER, Ilona DOHNALOVÁ and Martina NOVOTNÁ. Zralost kostry a rozvoj tělesné výšky u dětí po léčbě zhoubných nádorů (Skeletal maturity and body heigh development in children after malignant tumour treatment). Medicina Sportiva Bohemica et Slovaca. Praha: ČSTL-ERILENS, 2000, vol. 9, No 3, p. 127-128. ISSN 1210-5481.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Zralost kostry a rozvoj tělesné výšky u dětí po léčbě zhoubných nádorů
Name (in English) Skeletal maturity and body heigh development in children after malignant tumour treatment
Authors NOVOTNÝ, Jan, Hana HRSTKOVÁ, Milan BAJER, Ilona DOHNALOVÁ and Martina NOVOTNÁ.
Edition Medicina Sportiva Bohemica et Slovaca, Praha, ČSTL-ERILENS, 2000, 1210-5481.
Other information
Original language Czech
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14510/00:00004040
Organization unit Faculty of Sports Studies
Keywords in English Skeletal maturity; body heigh development; malignant tumour treatment; children
Tags body heigh development, children, malignant tumour treatment, Skeletal maturity
Changed by Changed by: prof. MUDr. Jan Novotný, CSc., učo 2457. Changed: 12/2/2002 10:37.
Abstract
Zralost kostry a rozvoj tělesné výšky u dětí po léčbě zhoubných nádorů
Abstract (in English)
We have found significant bone age retardation in comparison with calendar age in girls, and we can not eliminate correlation between this retardation and long-term bone metabolic changes after steroid therapy. We have not found similar changes of bone age retardation in boys as in girls. We have not found some significant disorders in body height development in the treated children. The side effects of the therapy can manifest after many years, therefore, there is a need for physical development monitoring during a long-term period.
Links
NE5920, research and development projectName: Screening toxické kardiomyopatie po kardiotoxické cytostatické léčbě v dětsví.
Investor: Ministry of Health of the CR, Screening of the toxic cardiomyopathy after cardiotoxical cytostatic therapy during childhood.
PrintDisplayed: 21/5/2024 13:39